1. Home
  2. BGLC vs ICU Comparison

BGLC vs ICU Comparison

Compare BGLC & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioNexus Gene Lab Corp

BGLC

BioNexus Gene Lab Corp

N/A

Current Price

$2.28

Market Cap

10.1M

Sector

Health Care

ML Signal

N/A

Logo SeaStar Medical Holding Corporation

ICU

SeaStar Medical Holding Corporation

N/A

Current Price

$2.65

Market Cap

9.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BGLC
ICU
Founded
2017
2018
Country
Malaysia
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.1M
9.1M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
BGLC
ICU
Price
$2.28
$2.65
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
8.7K
54.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
45.78
N/A
EPS
N/A
N/A
Revenue
$9,510,646.00
N/A
Revenue This Year
N/A
$1,043.70
Revenue Next Year
N/A
$54.99
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.23
$0.22
52 Week High
$15.19
$2.98

Technical Indicators

Market Signals
Indicator
BGLC
ICU
Relative Strength Index (RSI) 36.35 60.15
Support Level $1.92 $2.26
Resistance Level $2.73 $2.78
Average True Range (ATR) 0.15 0.18
MACD 0.05 -0.02
Stochastic Oscillator 13.11 61.16

Price Performance

Historical Comparison
BGLC
ICU

About BGLC BioNexus Gene Lab Corp

BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.

About ICU SeaStar Medical Holding Corporation

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

Share on Social Networks: